Report Detail

Request for Sample of this report

Service & Software Global Ophthalmology AI Screening Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4683827
    • |
  • 06 March, 2026
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR
    • |
  • Service & Software

According to our (Global Info Research) latest study, the global Ophthalmology AI Screening Software market size was valued at US$ 2091 million in 2025 and is forecast to a readjusted size of US$ 11284 million by 2032 with a CAGR of 27.5% during review period.
Ophthalmic AI screening software is an artificial intelligence software used in the field of ophthalmic disease screening. It is based on deep learning algorithms and realizes automatic screening, auxiliary diagnosis and condition assessment of ophthalmic diseases by analyzing ophthalmic related data such as fundus images.
The prospects for ophthalmic AI screening software are broad, and it is currently at a critical stage of evolution from "single-disease-assisted detection" to "comprehensive multi-disease assessment and systemic health early warning." The market growth drivers are clear: the increase in the global diabetic patient population and the aging population has driven up the rigid demand for early eye disease screening; continuous progress in deep learning technology has improved the accuracy and reliability of algorithms; at the same time, supportive regulatory policies and exploration of medical insurance payment are accelerating its clinical implementation. In the future, this field will exhibit three major trends: First, technological integration, which will be combined with portable devices and telemedicine platforms to expand screening scenarios from hospitals to grassroots communities and even homes; second, functional diversification, extending from single eye disease screening to predicting disease progression and assessing overall health; and third, ecosystem systematization, integrating into the closed loop of "prevention-screening-diagnosis-management" and becoming an important digital infrastructure for eye health and even chronic disease management systems.
This report is a detailed and comprehensive analysis for global Ophthalmology AI Screening Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ophthalmology AI Screening Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Ophthalmology AI Screening Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Ophthalmology AI Screening Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Ophthalmology AI Screening Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ophthalmology AI Screening Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ophthalmology AI Screening Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eyenuk, Inc., DeepMind, Remidio, Retmarker, AEYE Health, RetinaLyze, Synapxe, Intelligent Retinal Imaging Systems, RetinAI, RetinaRisk, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Ophthalmology AI Screening Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
On-premises
Cloud-based
Market segment by Technology/Imaging Fundamentals
AI Based on Fundus Images
AI Based on OCT
Market segment by Core Functions
Disease Screening and Assisted Diagnosis Software
Systemic Health Risk Assessment Software
Market segment by Application
Hospital
Eye Clinic
Medical Research
Others
Market segment by players, this report covers
Eyenuk, Inc.
DeepMind
Remidio
Retmarker
AEYE Health
RetinaLyze
Synapxe
Intelligent Retinal Imaging Systems
RetinAI
RetinaRisk
CSIRO
Airdoc
Silicon Intelligence
Zhiyuan Huitu
WeDoctor Group
VoxelCloud
Kangfuzi Health
Zhenhealth
Tencent Health
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Ophthalmology AI Screening Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Ophthalmology AI Screening Software, with revenue, gross margin, and global market share of Ophthalmology AI Screening Software from 2021 to 2026.
Chapter 3, the Ophthalmology AI Screening Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Ophthalmology AI Screening Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ophthalmology AI Screening Software.
Chapter 13, to describe Ophthalmology AI Screening Software research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Ophthalmology AI Screening Software by Type
    • 1.3.1 Overview: Global Ophthalmology AI Screening Software Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Ophthalmology AI Screening Software Consumption Value Market Share by Type in 2025
    • 1.3.3 On-premises
    • 1.3.4 Cloud-based
  • 1.4 Classification of Ophthalmology AI Screening Software by Technology/Imaging Fundamentals
    • 1.4.1 Overview: Global Ophthalmology AI Screening Software Market Size by Technology/Imaging Fundamentals: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Ophthalmology AI Screening Software Consumption Value Market Share by Technology/Imaging Fundamentals in 2025
    • 1.4.3 AI Based on Fundus Images
    • 1.4.4 AI Based on OCT
  • 1.5 Classification of Ophthalmology AI Screening Software by Core Functions
    • 1.5.1 Overview: Global Ophthalmology AI Screening Software Market Size by Core Functions: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Ophthalmology AI Screening Software Consumption Value Market Share by Core Functions in 2025
    • 1.5.3 Disease Screening and Assisted Diagnosis Software
    • 1.5.4 Systemic Health Risk Assessment Software
  • 1.6 Global Ophthalmology AI Screening Software Market by Application
    • 1.6.1 Overview: Global Ophthalmology AI Screening Software Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Eye Clinic
    • 1.6.4 Medical Research
    • 1.6.5 Others
  • 1.7 Global Ophthalmology AI Screening Software Market Size & Forecast
  • 1.8 Global Ophthalmology AI Screening Software Market Size and Forecast by Region
    • 1.8.1 Global Ophthalmology AI Screening Software Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Ophthalmology AI Screening Software Market Size by Region, (2021-2032)
    • 1.8.3 North America Ophthalmology AI Screening Software Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Ophthalmology AI Screening Software Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Ophthalmology AI Screening Software Market Size and Prospect (2021-2032)
    • 1.8.6 South America Ophthalmology AI Screening Software Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Ophthalmology AI Screening Software Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Eyenuk, Inc.
    • 2.1.1 Eyenuk, Inc. Details
    • 2.1.2 Eyenuk, Inc. Major Business
    • 2.1.3 Eyenuk, Inc. Ophthalmology AI Screening Software Product and Solutions
    • 2.1.4 Eyenuk, Inc. Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Eyenuk, Inc. Recent Developments and Future Plans
  • 2.2 DeepMind
    • 2.2.1 DeepMind Details
    • 2.2.2 DeepMind Major Business
    • 2.2.3 DeepMind Ophthalmology AI Screening Software Product and Solutions
    • 2.2.4 DeepMind Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 DeepMind Recent Developments and Future Plans
  • 2.3 Remidio
    • 2.3.1 Remidio Details
    • 2.3.2 Remidio Major Business
    • 2.3.3 Remidio Ophthalmology AI Screening Software Product and Solutions
    • 2.3.4 Remidio Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Remidio Recent Developments and Future Plans
  • 2.4 Retmarker
    • 2.4.1 Retmarker Details
    • 2.4.2 Retmarker Major Business
    • 2.4.3 Retmarker Ophthalmology AI Screening Software Product and Solutions
    • 2.4.4 Retmarker Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Retmarker Recent Developments and Future Plans
  • 2.5 AEYE Health
    • 2.5.1 AEYE Health Details
    • 2.5.2 AEYE Health Major Business
    • 2.5.3 AEYE Health Ophthalmology AI Screening Software Product and Solutions
    • 2.5.4 AEYE Health Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 AEYE Health Recent Developments and Future Plans
  • 2.6 RetinaLyze
    • 2.6.1 RetinaLyze Details
    • 2.6.2 RetinaLyze Major Business
    • 2.6.3 RetinaLyze Ophthalmology AI Screening Software Product and Solutions
    • 2.6.4 RetinaLyze Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 RetinaLyze Recent Developments and Future Plans
  • 2.7 Synapxe
    • 2.7.1 Synapxe Details
    • 2.7.2 Synapxe Major Business
    • 2.7.3 Synapxe Ophthalmology AI Screening Software Product and Solutions
    • 2.7.4 Synapxe Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Synapxe Recent Developments and Future Plans
  • 2.8 Intelligent Retinal Imaging Systems
    • 2.8.1 Intelligent Retinal Imaging Systems Details
    • 2.8.2 Intelligent Retinal Imaging Systems Major Business
    • 2.8.3 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Product and Solutions
    • 2.8.4 Intelligent Retinal Imaging Systems Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Intelligent Retinal Imaging Systems Recent Developments and Future Plans
  • 2.9 RetinAI
    • 2.9.1 RetinAI Details
    • 2.9.2 RetinAI Major Business
    • 2.9.3 RetinAI Ophthalmology AI Screening Software Product and Solutions
    • 2.9.4 RetinAI Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 RetinAI Recent Developments and Future Plans
  • 2.10 RetinaRisk
    • 2.10.1 RetinaRisk Details
    • 2.10.2 RetinaRisk Major Business
    • 2.10.3 RetinaRisk Ophthalmology AI Screening Software Product and Solutions
    • 2.10.4 RetinaRisk Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 RetinaRisk Recent Developments and Future Plans
  • 2.11 CSIRO
    • 2.11.1 CSIRO Details
    • 2.11.2 CSIRO Major Business
    • 2.11.3 CSIRO Ophthalmology AI Screening Software Product and Solutions
    • 2.11.4 CSIRO Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 CSIRO Recent Developments and Future Plans
  • 2.12 Airdoc
    • 2.12.1 Airdoc Details
    • 2.12.2 Airdoc Major Business
    • 2.12.3 Airdoc Ophthalmology AI Screening Software Product and Solutions
    • 2.12.4 Airdoc Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Airdoc Recent Developments and Future Plans
  • 2.13 Silicon Intelligence
    • 2.13.1 Silicon Intelligence Details
    • 2.13.2 Silicon Intelligence Major Business
    • 2.13.3 Silicon Intelligence Ophthalmology AI Screening Software Product and Solutions
    • 2.13.4 Silicon Intelligence Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Silicon Intelligence Recent Developments and Future Plans
  • 2.14 Zhiyuan Huitu
    • 2.14.1 Zhiyuan Huitu Details
    • 2.14.2 Zhiyuan Huitu Major Business
    • 2.14.3 Zhiyuan Huitu Ophthalmology AI Screening Software Product and Solutions
    • 2.14.4 Zhiyuan Huitu Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Zhiyuan Huitu Recent Developments and Future Plans
  • 2.15 WeDoctor Group
    • 2.15.1 WeDoctor Group Details
    • 2.15.2 WeDoctor Group Major Business
    • 2.15.3 WeDoctor Group Ophthalmology AI Screening Software Product and Solutions
    • 2.15.4 WeDoctor Group Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 WeDoctor Group Recent Developments and Future Plans
  • 2.16 VoxelCloud
    • 2.16.1 VoxelCloud Details
    • 2.16.2 VoxelCloud Major Business
    • 2.16.3 VoxelCloud Ophthalmology AI Screening Software Product and Solutions
    • 2.16.4 VoxelCloud Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 VoxelCloud Recent Developments and Future Plans
  • 2.17 Kangfuzi Health
    • 2.17.1 Kangfuzi Health Details
    • 2.17.2 Kangfuzi Health Major Business
    • 2.17.3 Kangfuzi Health Ophthalmology AI Screening Software Product and Solutions
    • 2.17.4 Kangfuzi Health Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Kangfuzi Health Recent Developments and Future Plans
  • 2.18 Zhenhealth
    • 2.18.1 Zhenhealth Details
    • 2.18.2 Zhenhealth Major Business
    • 2.18.3 Zhenhealth Ophthalmology AI Screening Software Product and Solutions
    • 2.18.4 Zhenhealth Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Zhenhealth Recent Developments and Future Plans
  • 2.19 Tencent Health
    • 2.19.1 Tencent Health Details
    • 2.19.2 Tencent Health Major Business
    • 2.19.3 Tencent Health Ophthalmology AI Screening Software Product and Solutions
    • 2.19.4 Tencent Health Ophthalmology AI Screening Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Tencent Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Ophthalmology AI Screening Software Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Ophthalmology AI Screening Software by Company Revenue
    • 3.2.2 Top 3 Ophthalmology AI Screening Software Players Market Share in 2025
    • 3.2.3 Top 6 Ophthalmology AI Screening Software Players Market Share in 2025
  • 3.3 Ophthalmology AI Screening Software Market: Overall Company Footprint Analysis
    • 3.3.1 Ophthalmology AI Screening Software Market: Region Footprint
    • 3.3.2 Ophthalmology AI Screening Software Market: Company Product Type Footprint
    • 3.3.3 Ophthalmology AI Screening Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Ophthalmology AI Screening Software Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Ophthalmology AI Screening Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Ophthalmology AI Screening Software Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Ophthalmology AI Screening Software Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Ophthalmology AI Screening Software Consumption Value by Type (2021-2032)
  • 6.2 North America Ophthalmology AI Screening Software Market Size by Application (2021-2032)
  • 6.3 North America Ophthalmology AI Screening Software Market Size by Country
    • 6.3.1 North America Ophthalmology AI Screening Software Consumption Value by Country (2021-2032)
    • 6.3.2 United States Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Ophthalmology AI Screening Software Consumption Value by Type (2021-2032)
  • 7.2 Europe Ophthalmology AI Screening Software Consumption Value by Application (2021-2032)
  • 7.3 Europe Ophthalmology AI Screening Software Market Size by Country
    • 7.3.1 Europe Ophthalmology AI Screening Software Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 7.3.3 France Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Ophthalmology AI Screening Software Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Ophthalmology AI Screening Software Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Ophthalmology AI Screening Software Market Size by Region
    • 8.3.1 Asia-Pacific Ophthalmology AI Screening Software Consumption Value by Region (2021-2032)
    • 8.3.2 China Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 8.3.5 India Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Ophthalmology AI Screening Software Consumption Value by Type (2021-2032)
  • 9.2 South America Ophthalmology AI Screening Software Consumption Value by Application (2021-2032)
  • 9.3 South America Ophthalmology AI Screening Software Market Size by Country
    • 9.3.1 South America Ophthalmology AI Screening Software Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Ophthalmology AI Screening Software Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Ophthalmology AI Screening Software Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Ophthalmology AI Screening Software Market Size by Country
    • 10.3.1 Middle East & Africa Ophthalmology AI Screening Software Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Ophthalmology AI Screening Software Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Ophthalmology AI Screening Software Market Drivers
  • 11.2 Ophthalmology AI Screening Software Market Restraints
  • 11.3 Ophthalmology AI Screening Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Ophthalmology AI Screening Software Industry Chain
  • 12.2 Ophthalmology AI Screening Software Upstream Analysis
  • 12.3 Ophthalmology AI Screening Software Midstream Analysis
  • 12.4 Ophthalmology AI Screening Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ophthalmology AI Screening Software. Industry analysis & Market Report on Ophthalmology AI Screening Software is a syndicated market report, published as Global Ophthalmology AI Screening Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ophthalmology AI Screening Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo